Sweden· SE-20100907000050
Komboglyze 2,5 mg/1000 mg Filmdragerad tablett
A medicinal product containing metformin hydrochloride + saxagliptin, registered in Sweden by AstraZeneca AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Metformin Hydrochloride + Saxagliptin
- Manufacturer
- AstraZeneca AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20100907000050
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Metformin hydrochloride + saxagliptin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKOMBOGLYZEAstraZeneca AB, Södertälje
- United StatesSaxagliptin and MetforminMylan Pharmaceuticals Inc.
- SwitzerlandKombiglyze XR
- United KingdomKomboglyze 2.5mg/1000mg tabletsAstraZeneca UK Ltd
- SpainKOMBOGLYZE 2,5 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAstrazeneca Ab
- CanadaKOMBOGLYZEASTRAZENECA CANADA INC
- IrelandKomboglyze 2.5 mg/1000 mg film-coated tabletsAstraZeneca AB
- IcelandKomboglyzeAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- France · Saxagliptine/Metformine Biogaran
- Iceland · Komboglyze
- Liechtenstein · Komboglyze
- Malta · Saxagliptin/Metformin Pharos
- Norway · Komboglyze
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc5ef00c-d3e1-422f-8725-dff819ac54f2 GET /v1/drugs/dc5ef00c-d3e1-422f-8725-dff819ac54f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20100907000050",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20100907000050",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/komboglyze-epar-product-information_sv.pdf"
}See everything about metformin hydrochloride + saxagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.